{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:58:09Z","timestamp":1775674689504,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003284","name":"Pulmonary Fibrosis Foundation","doi-asserted-by":"publisher","award":["PFF Scholar"],"award-info":[{"award-number":["PFF Scholar"]}],"id":[{"id":"10.13039\/100003284","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002649"],"award-info":[{"award-number":["UL1TR002649"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004360"],"award-info":[{"award-number":["UM1TR004360"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["5D43TW009340-13"],"award-info":[{"award-number":["5D43TW009340-13"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Post-tuberculosis lung disease (PTLD) is a frequent complication after TB cure, affecting millions globally. Yet, its mechanisms, particularly the role of lipid mediators (LMs) in resolution of inflammation are not clear. This study aimed to identify inflammatory and resolution signatures by comparing longitudinal LM profiles in plasma and exhaled breath condensate (EBC) between TB patients who developed PTLD and those with normal lung recovery.In this prospective cohort study, plasma and EBC were collected at diagnosis and post-TB treatment (generally 6 months). Twenty subjects were selected for analysis following TB treatment, 10 cases (impaired lung function indicative of PTLD) and 10 controls (normal lung function). LM analysis was performed using LC-MS\/MS. Group comparisons and longitudinal changes were analyzed using differential abundance analyses (limma) with multiple testing correction with sequential goodness-of-fit adjusted p-values.Baseline plasma analysis showed higher PD1, 12-HEPE, 10-HDoHE, 11-HDoHE, 12-HETE, and 13(14)-EpDPE with significantly lower concentrations of PGA2 in cases vs. controls. Post-treatment, cases had lower AT-RvD6 and 15-oxo-LXA4. Longitudinal plasma analysis with linear modeling showed decreased PD1 in cases during treatment relative to controls. EBC analysis showed no significant differences between group or longitudinal linear comparisons.Distinct systemic lipid mediator profiles and their longitudinal trajectories differ between TB patients who subsequently develop PTLD and those who achieve normal lung recovery. Cases showed an altered LM profile at diagnosis that evolved into a post-treatment state with pro-resolving mediator deficiencies and failed to normalize baseline alterations, suggesting dysregulated resolution pathways in PTLD pathogenesis.<\/jats:p>","DOI":"10.1371\/journal.pgph.0006097","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:51:52Z","timestamp":1775670712000},"page":"e0006097","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal analysis of lipid mediators in post-tuberculosis lung disease identifies significant differences"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5108-9381","authenticated-orcid":true,"given":"Peter D.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline","family":"Helwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8635-2925","authenticated-orcid":true,"given":"Mudarshiru","family":"Bbuye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Freeberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-3041","authenticated-orcid":true,"given":"Thomas H.","family":"Thatcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Zawedde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Kirenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Worodria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnarao","family":"Maddipati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-1839","authenticated-orcid":true,"given":"Trishul","family":"Siddharthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin","family":"Reyna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"Sime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"pgph.0006097.ref001","unstructured":"Global Tuberculosis Report; 2025 [cited 2026 Feb 10]. Available from: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025"},{"key":"pgph.0006097.ref002","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijid.2014.12.016","article-title":"Tuberculosis and chronic respiratory disease: a systematic review","volume":"32","author":"AL Byrne","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"8","key":"pgph.0006097.ref003","doi-asserted-by":"crossref","first-page":"820","DOI":"10.5588\/ijtld.20.0067","article-title":"Post-tuberculosis lung health: perspectives from the First International Symposium","volume":"24","author":"BW Allwood","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10277","key":"pgph.0006097.ref004","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(21)00458-X","article-title":"Improving lung health in low-income and middle-income countries: from challenges to solutions","volume":"397","author":"J Meghji","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"pgph.0006097.ref005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000805","article-title":"Magnitude and factors associated with post-tuberculosis lung disease in low- and middle-income countries: a systematic review and meta-analysis","volume":"2","author":"E Maleche-Obimbo","year":"2022","journal-title":"PLOS Glob Public Health"},{"issue":"7","key":"pgph.0006097.ref006","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S1473-3099(20)30919-1","article-title":"Quantifying the global number of tuberculosis survivors: a modelling study","volume":"21","author":"PJ Dodd","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"pgph.0006097.ref007","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(19)30309-3","article-title":"Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis","volume":"19","author":"K Romanowski","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"147","key":"pgph.0006097.ref008","doi-asserted-by":"crossref","first-page":"170077","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"S Ravimohan","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"4","key":"pgph.0006097.ref009","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2213-2600(20)30039-4","article-title":"Post-tuberculosis mortality and morbidity: valuing the hidden epidemic","volume":"8","author":"M Quaife","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"7503","key":"pgph.0006097.ref010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"CN Serhan","year":"2014","journal-title":"Nature"},{"issue":"3","key":"pgph.0006097.ref011","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"N Chiang","year":"2020","journal-title":"Essays Biochem"},{"issue":"8","key":"pgph.0006097.ref012","article-title":"Roles of eicosanoids in regulating inflammation and neutrophil migration as an innate host response to bacterial infections","volume":"89","author":"AEF Sheppe","year":"2021","journal-title":"Infect Immun"},{"key":"pgph.0006097.ref013","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejphar.2015.11.001","article-title":"DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation","volume":"785","author":"MG Duvall","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"pgph.0006097.ref014","first-page":"171","article-title":"Plasma levels of specialized pro-resolving mediators are associated with the severity of pulmonary tuberculosis","volume":"108","author":"J Che","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"12","key":"pgph.0006097.ref015","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1084\/jem.20080767","article-title":"Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death","volume":"205","author":"M Chen","year":"2008","journal-title":"J Exp Med"},{"key":"pgph.0006097.ref016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fcimb.2019.00335","article-title":"Plasma eicosanoid levels in tuberculosis and tuberculosis-diabetes co-morbidity are associated with lung pathology and bacterial burden","volume":"9","author":"N Pavan Kumar","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"pgph.0006097.ref017","doi-asserted-by":"crossref","first-page":"13028","DOI":"10.1096\/fj.201901590R","article-title":"Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis","volume":"33","author":"RA Colas","year":"2019","journal-title":"FASEB J"},{"issue":"1","key":"pgph.0006097.ref018","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1753465807082373","article-title":"Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications","volume":"1","author":"P Montuschi","year":"2007","journal-title":"Ther Adv Respir Dis"},{"issue":"2","key":"pgph.0006097.ref019","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"MR Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"6","key":"pgph.0006097.ref020","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"PH Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"pgph.0006097.ref021","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.prostaglandins.2011.01.003","article-title":"Stability and analysis of eicosanoids and docosanoids in tissue culture media","volume":"94","author":"KR Maddipati","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"11","key":"pgph.0006097.ref022","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1096\/fj.14-254383","article-title":"Eicosanomic profiling reveals dominance of the epoxygenase pathway in human amniotic fluid at term in spontaneous labor","volume":"28","author":"KR Maddipati","year":"2014","journal-title":"FASEB J"},{"issue":"10","key":"pgph.0006097.ref023","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1096\/fj.201600583R","article-title":"Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up-regulation of leukotriene B4","volume":"30","author":"KR Maddipati","year":"2016","journal-title":"FASEB J"},{"issue":"10","key":"pgph.0006097.ref024","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1194\/jlr.P069096","article-title":"Clinical chorioamnionitis at term: the amniotic fluid fatty acyl lipidome","volume":"57","author":"KR Maddipati","year":"2016","journal-title":"J Lipid Res"},{"issue":"2","key":"pgph.0006097.ref025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41592-022-01710-0","article-title":"Guiding the choice of informatics software and tools for lipidomics research applications","volume":"20","author":"Z Ni","year":"2023","journal-title":"Nat Methods"},{"issue":"3","key":"pgph.0006097.ref026","article-title":"The Global Lung Function Initiative (GLI) Network: bringing the world\u2019s respiratory reference values together","volume":"13","author":"BG Cooper","year":"2017","journal-title":"Breathe (Sheff)"},{"issue":"8","key":"pgph.0006097.ref027","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"EA Dennis","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"pgph.0006097.ref028","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"CN Serhan","year":"2018","journal-title":"J Clin Invest"},{"issue":"1","key":"pgph.0006097.ref029","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"MC Basil","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"pgph.0006097.ref030","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/IAI.69.3.1847-1855.2001","article-title":"Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology","volume":"69","author":"VP Mohan","year":"2001","journal-title":"Infect Immun"},{"issue":"1","key":"pgph.0006097.ref031","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/imr.12249","article-title":"Cytokine and lipid mediator networks in tuberculosis","volume":"264","author":"KD Mayer-Barber","year":"2015","journal-title":"Immunol Rev"},{"issue":"6","key":"pgph.0006097.ref032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129744","article-title":"Mycobacterium tuberculosis-induced polarization of human macrophage orchestrates the formation and development of tuberculous granulomas in vitro","volume":"10","author":"Z Huang","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"pgph.0006097.ref033","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051677","article-title":"Resolvins, protectins, and maresins: DHA-derived specialized pro-resolving mediators, biosynthetic pathways, synthetic approaches, and their role in inflammation","volume":"27","author":"I Ferreira","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"pgph.0006097.ref034","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001687R","article-title":"\u03c93 fatty acid metabolite, 12-hydroxyeicosapentaenoic acid, alleviates contact hypersensitivity by downregulation of CXCL1 and CXCL2 gene expression in keratinocytes via retinoid X receptor \u03b1","volume":"35","author":"A Saika","year":"2021","journal-title":"FASEB J"},{"issue":"5","key":"pgph.0006097.ref035","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/biom11050717","article-title":"Regulation of tissue inflammation by 12-lipoxygenases","volume":"11","author":"A Kulkarni","year":"2021","journal-title":"Biomolecules"},{"issue":"8","key":"pgph.0006097.ref036","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00125.2015","article-title":"Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages","volume":"309","author":"A Croasdell","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"pgph.0006097.ref037","doi-asserted-by":"crossref","first-page":"101605","DOI":"10.1016\/j.smim.2022.101605","article-title":"Specialized pro-resolving mediators as modulators of immune responses","volume":"59","author":"WA Julliard","year":"2022","journal-title":"Semin Immunol"},{"issue":"12","key":"pgph.0006097.ref038","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/j.ajpath.2015.08.008","article-title":"Resolvin D1 reduces emphysema and chronic inflammation","volume":"185","author":"H-M Hsiao","year":"2015","journal-title":"Am J Pathol"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:52:03Z","timestamp":1775670723000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006097"}},"subtitle":[],"editor":[{"given":"Paulo Jorge Gon\u00e7alves de","family":"Bettencourt","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0006097","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]}}}